Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

IBIO Insider Trading

iBio, Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at iBio, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-01-14 00:34 2025-01-10 Duran Felipe Officer - Chief Financial Officer BUY $2.72 9,191 $25,000 11,139 +471.8%
2025-01-14 00:34 2025-01-10 Brenner Martin Director, Officer - See Remarks BUY $2.72 9,191 $25,000 18,316 +100.7%
2025-01-14 00:33 2025-01-10 Banjak Marc Officer - Chief Legal Officer BUY $2.72 9,191 $25,000 11,066 +490.2%
2025-01-14 00:32 2025-01-10 Arkowitz David Director BUY $2.72 18,382 $49,999 18,382 +100.0%
2025-01-14 00:31 2025-01-10 Clark William D Director BUY $2.72 1,838 $4,999 1,838 +100.0%
2025-01-14 00:30 2025-01-10 Parada Antonio Bernardino Guimaraes Director BUY $2.72 183,823 $499,999 183,823 +100.0%
2025-01-14 00:30 2025-01-10 Sender Gary Director BUY $2.72 9,191 $25,000 9,191 +100.0%
2023-11-03 23:01 2023-11-01 Brenner Martin Officer - See Remarks SELL $0.27 4,881 $1,296 182,502 -2.6%
2023-10-05 23:01 2023-10-03 Brenner Martin Officer - See Remarks SELL $0.30 5,267 $1,592 187,383 -2.7%
2023-10-03 23:01 2023-10-02 Brenner Martin Officer - See Remarks SELL $0.31 4,215 $1,311 192,650 -2.1%
2023-08-30 23:22 2023-08-28 Brenner Martin Officer - See Remarks SELL $0.31 5,011 $1,529 196,865 -2.5%
2023-07-28 23:01 2023-07-27 Brenner Martin Officer - See Remarks SELL $0.51 4,515 $2,308 201,876 -2.2%
2023-07-13 23:02 2023-07-12 Brenner Martin Officer - See Remarks SELL $0.59 47,020 $27,521 206,391 -18.6%
2023-06-22 16:28 2023-06-21 Brenner Martin Officer - See Remarks SELL $0.68 4,184 $2,849 253,411 -1.6%
2023-05-24 13:03 2023-05-22 Brenner Martin Officer - See Remarks SELL $0.94 4,182 $3,911 257,595 -1.6%
2023-04-24 23:01 2023-04-24 Brenner Martin Officer - See Remarks SELL $1.20 4,382 $5,258 261,777 -1.6%
2023-03-28 15:32 2023-03-23 Brenner Martin Officer - See Remarks SELL $2.13 5,213 $11,112 216,159 -2.4%
2023-02-24 00:31 2023-02-21 Brenner Martin Officer - See Remarks SELL $1.77 3,976 $7,038 221,372 -1.8%
2022-03-14 23:12 2022-03-10 Lutz Robert Matthew Officer - See Remarks SELL $0.35 24,625 $8,510 207,375 -10.6%
2020-08-12 00:08 2020-08-07 Eastern Capital LTD 10% owner SELL $3.27 24,484,904 $79,945,660 8,629,693 -73.9%
2020-08-07 00:33 2020-08-04 Eastern Capital LTD 10% owner SELL $4.27 4,268,137 $18,220,677 33,114,597 -11.4%
2020-06-08 19:41 2020-06-04 ERWIN ROBERT L Officer - President OPT+S $1.71 28,268 $48,338 108,108 0.0%
2020-06-05 13:04 2020-06-02 ERWIN ROBERT L Officer - President OPT+S $1.62 96,124 $155,721 136,376 0.0%
2020-05-29 19:45 2020-05-27 Mullaney James P. Officer - Chief Financial Officer OPT+S $1.61 11,250 $18,113 0 0.0%
2018-07-13 23:06 2018-07-12 Eastern Capital LTD 10% owner BUY $0.90 2,200,000 $1,980,000 8,457,734 +35.2%
2018-06-29 01:03 2018-06-26 Eastern Capital LTD 10% owner BUY $0.90 1,683,334 $1,515,001 6,257,734 +36.8%
2017-02-27 23:39 2017-02-23 DART KENNETH BRYAN 10% owner BUY $0.00 1 $0 1 +100.0%
2016-04-11 21:58 2016-04-07 Eastern Capital LTD 10% owner BUY $0.62 6,500,000 $4,043,000 33,744,000 +23.9%
2016-01-27 20:12 2016-01-25 Eastern Capital LTD 10% owner BUY $0.62 3,500,000 $2,177,000 25,460,000 +15.9%
2014-09-19 00:11 2014-09-15 DESANTIS CARL 10% owner SELL $0.67 138,710 $93,033 5,751,143 -2.4%
2014-02-05 02:28 2014-02-03 DESANTIS CARL 10% owner SELL $0.55 28,828 $15,855 5,889,853 -0.5%
2014-02-05 02:04 2014-01-30 DESANTIS CARL 10% owner SELL $0.56 74,049 $41,275 5,918,681 -1.2%
2014-02-05 01:24 2013-12-11 DESANTIS CARL 10% owner SELL $0.53 159,341 $84,706 5,992,730 -2.6%
2014-02-01 01:13 2014-01-30 DESANTIS CARL 10% owner SELL $0.56 74,049 $41,275 5,949,314 -1.2%
2014-01-30 01:10 2014-01-24 DESANTIS CARL 10% owner SELL $0.58 128,708 $74,277 6,023,363 -2.1%
2013-09-03 20:34 2013-08-13 DESANTIS CARL 10% owner SELL $0.50 37,689 $18,845 6,152,071 -0.6%
2013-09-03 20:15 2013-08-07 DESANTIS CARL 10% owner SELL $0.54 324,395 $173,616 6,189,760 -5.0%
2013-09-03 19:43 2013-08-05 DESANTIS CARL 10% owner SELL $0.50 53,065 $26,761 6,514,155 -0.8%
2013-09-03 19:28 2013-07-31 DESANTIS CARL 10% owner SELL $0.50 99,945 $49,973 6,570,220 -1.5%
2013-09-03 19:05 2013-07-29 DESANTIS CARL 10% owner SELL $0.51 34,605 $17,493 6,670,165 -0.5%
2013-09-03 18:53 2013-07-25 DESANTIS CARL 10% owner SELL $0.50 27,255 $13,698 6,704,770 -0.4%
2013-09-03 18:11 2013-07-23 DESANTIS CARL 10% owner SELL $0.51 39,465 $20,127 6,732,025 -0.6%
2013-09-03 17:45 2013-07-19 DESANTIS CARL 10% owner BUY $0.52 1,732,679 $900,993 6,771,490 +34.4%
2013-04-30 22:37 2013-04-26 Eastern Capital LTD 10% owner BUY $0.00 4,460,000 $0 14,460,000 +44.6%
2012-06-30 01:46 2012-06-27 KAY E GERALD 10% owner SELL $0.76 150,000 $114,000 4,119,803 -3.5%
2012-03-28 23:24 2012-03-14 MCKEY JOHN D JR Director SELL $0.99 26,411 $26,255 968,284 -2.7%
2012-03-28 23:23 2012-03-13 MCKEY JOHN D JR Director SELL $1.10 21,509 $23,585 994,695 -2.1%
2012-03-28 23:23 2012-03-09 MCKEY JOHN D JR Director SELL $1.10 11,575 $12,733 1,016,204 -1.1%
2012-03-16 21:44 2012-03-14 MCKEY JOHN D JR Director SELL $0.99 26,411 $26,255 868,284 -3.0%
2012-03-14 22:29 2012-03-13 MCKEY JOHN D JR Director SELL $1.10 21,509 $23,585 894,695 -2.3%
SHOW ENTRIES
1-50 OF 57

How to Interpret $IBIO Trades

Not every insider transaction in iBio, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $IBIO shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for IBIO

Insider activity data for iBio, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $IBIO, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.